Discovery of first-in-class DOT1L inhibitors against the R231Q gain-of-function mutation in the catalytic domain with therapeutic potential of lung cancer
-
Published:2024-08
Issue:8
Volume:14
Page:3605-3623
-
ISSN:2211-3835
-
Container-title:Acta Pharmaceutica Sinica B
-
language:en
-
Short-container-title:Acta Pharmaceutica Sinica B
Author:
Tan Zehui,
Guo Ning,
Cao Zhi,
Liu Shuyu,
Zhang Jiayu,
Ma DeyiORCID,
Zhang Jiahao,
Lv Wencai,
Jiang Nan,
Zang Linghe,
Wang Lihui,
Zhai Xin
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献